Intranasal delivery of bone marrow mesenchymal stem cells improved neurovascular regeneration and rescued neuropsychiatric deficits after neonatal stroke in rats

Cell Transplantation

Volumn 24, Issue 3, 2015, Pages 391-402

  Wei, Zheng Zachory ^a,b   Gu, Xiaohuan ^a   Ferdinand, Anwar ^a   Lee, Jin Hwan ^a   Ji, Xiaoya ^a   Ji, Xun Ming ^c   Yu, Shan Ping ^a,b   Wei, Ling ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Bone marrow mesenchymal stem cells (BMSCs); Intranasal; Neonate; Regeneration; Stroke

Indexed keywords

ADHESIVE REMOVAL TEST; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BLOOD BRAIN BARRIER; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN INFARCTION SIZE; CELL THERAPY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ISCHEMIC PRECONDITIONING; MALE; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; OLFACTORY CORTEX; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; SMELLING; ANIMAL; ANIMAL BEHAVIOR; BONE MARROW CELL; CONVALESCENCE; CYTOLOGY; INTRANASAL DRUG ADMINISTRATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NERVE CELL; NEWBORN; OLFACTORY BULB; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION; SENSORIMOTOR CORTEX; STROKE; VASCULARIZATION; VEIN; WISTAR RAT;

ANIMALIA; RATTUS;

ADMINISTRATION, INTRANASAL; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BLOOD-BRAIN BARRIER; BONE MARROW CELLS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PATHOLOGIC; NEUROGENESIS; NEURONS; OLFACTORY BULB; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; REGENERATION; SENSORIMOTOR CORTEX; STROKE; VEINS;

EID: 84927127896     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368915X686887     Document Type: Article

References (70)

1. Adriani, W.; Giannakopoulou, D.; Bokulic, Z.; Jernej, B.; Alleva, E.; Laviola, G. Response to novelty, social and self-control behaviors, in rats exposed to neonatal anoxia: Modulatory effects of an enriched environment. Psychopharmacology 184(2):155–165; 2006.
2. Bae, J. S.; Jin, H. K.; Lee, J. K.; Richardson, J. C.; Carter, J. E. Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-beta deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer’s disease. Curr. Alzheimer Res. 10(5):524–531; 2013.
3. Baharnoori, M.; Bhardwaj, S. K.; Srivastava, L. K. Neonatal behavioral changes in rats with gestational exposure to lipopolysaccharide: A prenatal infection model for developmental neuropsychiatric disorders. Schizophr. Bull. 38(3): 444–456; 2012.
4. Barzilay, R.; Ganz, J.; Sadan, O.; Ben-Zur, T.; Bren, Z.; Hinden, N.; Taler, M.; Lev, N.; Gil-Ad, I.; Weizman, A.; Offen, D. Mesenchymal stem cells protect from sub-chronic phencyclidine insult in vivo and counteract changes in astrocyte gene expression in vitro. Eur. Neuropsychopharmacol. 23(9):1115–1123; 2013.
5. Bouet, V.; Boulouard, M.; Toutain, J.; Divoux, D.; Bernaudin, M.; Schumann-Bard, P.; Freret, T. The adhesive removal test: A sensitive method to assess sensorimotor deficits in mice. Nat. Protoc. 4(10):1560–1564; 2009.
6. Chen, A.; Siow, B.; Blamire, A. M.; Lako, M.; Clowry, G. J. Transplantation of magnetically labeled mesenchymal stem cells in a model of perinatal brain injury. Stem Cell Res. 5(3):255–266; 2010.
7. Chuang, D. M.; Wang, Z.; Chiu, C. T. GSK-3 as a target for lithium-induced neuroprotection against excitotoxicity in neuronal cultures and animal models of ischemic stroke. Front. Mol. Neurosci. 4:15; 2011.
8. Danielyan, L.; Schafer, R.; von Ameln-Mayerhofer, A.; Buadze, M.; Geisler, J.; Klopfer, T.; Burkhardt, U.; Proksch, B.; Verleysdonk, S.; Ayturan, M.; Buniatian, G. H.; Gleiter, C. H.; Frey, W. H. 2nd. Intranasal delivery of cells to the brain. Eur. J. Cell Biol. 88(6):315–324; 2009.
9. Dean, J. M.; Moravec, M. D.; Grafe, M.; Abend, N.; Ren, J.; Gong, X.; Volpe, J. J.; Jensen, F. E.; Hohimer, A. R.; Back, S. A. Strain-specific differences in perinatal rodent oligodendrocyte lineage progression and its correlation with human. Dev. Neurosci. 33(3–4):251–260; 2011.
10. Dhuria, S. V.; Hanson, L. R.; Frey, W. H. 2nd Intranasal delivery to the central nervous system: Mechanisms and experimental considerations. J Pharm. Sci. 99(4):1654–1673; 2010.
11. Donega, V.; Nijboer, C. H.; van Tilborg, G.; Dijkhuizen, R. M.; Kavelaars, A.; Heijnen, C. J. Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury. Exp. Neurol. 261:53–64; 2014.
12. Donega, V.; van Velthoven, C. T.; Nijboer, C. H.; van Bel, F.; Kas, M. J.; Kavelaars, A.; Heijnen, C. J. Intranasal mesenchymal stem cell treatment for neonatal brain damage: Long-term cognitive and sensorimotor improvement. PloS One 8(1):e51253; 2013.
13. Drago, D.; Cossetti, C.; Iraci, N.; Gaude, E.; Musco, G.; Bachi, A.; Pluchino, S. The stem cell secretome and its role in brain repair. Biochimie 95(12):2271–2285; 2013.
14. Dzietko, M.; Derugin, N.; Wendland, M. F.; Vexler, Z. S.; Ferriero, D. M. Delayed VEGF treatment enhances angiogenesis and recovery after neonatal focal rodent stroke. Transl. Stroke Res. 4(2):189–200; 2013.
15. Eckert, M. A.; Vu, Q.; Xie, K.; Yu, J.; Liao, W.; Cramer, S. C.; Zhao, W. Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke. J. Cereb. Blood Flow Metab. 33(9): 1322–1334; 2013.
16. Fernandez-Lopez, D.; Natarajan, N.; Ashwal, S.; Vexler, Z. S. Mechanisms of perinatal arterial ischemic stroke. J. Cereb. Blood Flow Metab. 34(6):921–932; 2014.
17. Gonzales-Portillo, G. S.; Sanberg, P. R.; Franzblau, M.; Gonzales-Portillo, C.; Diamandis, T.; Staples, M.; Sanberg, C. D.; Borlongan, C. V. Mannitol-enhanced delivery of stem cells and their growth factors across the blood-brain barrier. Cell Transplant. 23(4–5):531–539; 2014.
18. Guo, F.; Lv, S.; Lou, Y.; Tu, W.; Liao, W.; Wang, Y.; Deng, Z. Bone marrow stromal cells enhance the angiogenesis in ischaemic cortex after stroke: Involvement of notch signalling. Cell Biol. Int. 36(11):997–1004; 2012.
19. Harbert, M. J.; Jett, M.; Appelbaum, M.; Nass, R.; Trauner, D. A. Perinatal risk factors and later social, thought, and attention problems after perinatal stroke. Stroke Res. Treat. 2012:914546; 2012.
20. Harris, V. K.; Faroqui, R.; Vyshkina, T.; Sadiq, S. A. Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis. Stem Cells Transl. Med. 1(7):536–547; 2012.
21. Heo, H.; Yoo, M.; Han, D.; Cho, Y.; Joung, I.; Kwon, Y. K. Upregulation of TrkB by forskolin facilitated survival of MSC and functional recovery of memory deficient model rats. Biochem. Biophys. Res. Commun. 431(4):796–801; 2013.
22. Honmou, O.; Houkin, K.; Matsunaga, T.; Niitsu, Y.; Ishiai, S.; Onodera, R.; Waxman, S. G.; Kocsis, J. D. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 134(Pt 6):1790–1807; 2011.
23. Honmou, O.; Onodera, R.; Sasaki, M.; Waxman, S. G.; Kocsis, J. D. Mesenchymal stem cells: Therapeutic outlook for stroke. Trends Mol. Med. 18(5):292–297; 2012.
24. Hu, X.; Wei, L.; Taylor, T. M.; Wei, J.; Zhou, X.; Wang, J. A.; Yu, S. P. Hypoxic preconditioning enhances bone marrow mesenchymal stem cell migration via Kv2.1 channel and FAK activation. Am. J. Physiol. Cell Physiol. 301(2):C362–C372; 2011.
25. Hu, X.; Yu, S. P.; Fraser, J. L.; Lu, Z.; Ogle, M. E.; Wang, J. A.; Wei, L. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J. Thorac. Cardiovasc. Surg. 135(4):799–808; 2008.
26. Huang, B.; Tabata, Y.; Gao, J. Q. Mesenchymal stem cells as therapeutic agents and potential targeted gene delivery vehicle for brain diseases. J. Control. Release 162(2):464–473; 2012.
27. Jiang, Y.; Zhu, J.; Xu, G.; Liu, X. Intranasal delivery of stem cells to the brain. Expert Opin. Drug Deliv. 8(5):623–632; 2011.
28. Johnston, M. V.; Fatemi, A.; Wilson, M. A.; Northington, F. Treatment advances in neonatal neuroprotection and neurointensive care. Lancet Neurol. 10(4):372–382; 2011.
29. Karussis, D.; Karageorgiou, C.; Vaknin-Dembinsky, A.; Gowda-Kurkalli, B.; Gomori, J. M.; Kassis, I.; Bulte, J. W.; Petrou, P.; Ben-Hur, T.; Abramsky, O.; Slavin, S. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch. Neurol. 67(10):1187–1194; 2010.
30. Keogh, C. L.; Yu, S. P.; Wei, L. The effect of recombinant human erythropoietin on neurovasculature repair after focal ischemic stroke in neonatal rats. J. Pharmacol. Exp. Ther. 322(2):521–528; 2007.
31. Khalili, M. A.; Anvari, M.; Hekmati-Moghadam, S. H.; Sadeghian-Nodoushan, F.; Fesahat, F.; Miresmaeili, S. M. Therapeutic benefit of intravenous transplantation of mesenchymal stem cells after experimental subarachnoid hemorrhage in rats. J. Stroke Cerebrovasc. Dis. 21(6):445–451; 2012.
32. Kim, E. S.; Ahn, S. Y.; Im, G. H.; Sung, D. K.; Park, Y. R.; Choi, S. H.; Choi, S. J.; Chang, Y. S.; Oh, W.; Lee, J. H.; Park, W. S. Human umbilical cord blood-derived mesenchymal stem cell transplantation attenuates severe brain injury by permanent middle cerebral artery occlusion in newborn rats. Pediatr. Res. 72(3):277–284; 2012.
33. Kim, J. W.; Ha, K. Y.; Molon, J. N.; Kim, Y. H. Bone marrow-derived mesenchymal stem cell transplantation for chronic spinal cord injury in rats: Comparative study between intralesional and intravenous transplantation. Spine 38(17):E1065–1074; 2013.
34. Kim, S. J.; Moon, G. J.; Chang, W. H.; Kim, Y. H.; Bang, O. Y. STARTING-2 (STem cell Application Researches and Trials In NeuroloGy-2) collaborators. Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: Current evidence and study protocol for a randomized trial. Trials 14:317; 2013.
35. Kocsis, J. D.; Honmou, O. Bone marrow stem cells in experimental stroke. Prog. Brain Res. 201:79–98; 2012.
36. Laviola, G.; Adriani, W.; Rea, M.; Aloe, L.; Alleva, E. Social withdrawal, neophobia, and stereotyped behavior in developing rats exposed to neonatal asphyxia. Psychopharmacology 175(2):196–205; 2004.
37. Lee, H.; Kang, J. E.; Lee, J. K.; Bae, J. S.; Jin, H. K. Bone-marrow-derived mesenchymal stem cells promote proliferation and neuronal differentiation of Niemann-Pick type C mouse neural stem cells by upregulation and secretion of CCL2. Hum. Gene Ther. 24(7):655–669; 2013.
38. Lee, J.; Croen, L. A.; Lindan, C.; Nash, K. B.; Yoshida, C. K.; Ferriero, D. M.; Barkovich, A. J.; Wu, Y. W. Predictors of outcome in perinatal arterial stroke: A population-based study. Ann. Neurol. 58(2):303–308; 2005.
39. Lee, J. K.; Schuchman, E. H.; Jin, H. K.; Bae, J. S. Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid beta ameliorates Alzheimer’s disease in mice by recruiting bone marrow-induced microglia immune responses. Stem Cells 30(7):1544–1555; 2012.
40. Lee, J. S.; Hong, J. M.; Moon, G. J.; Lee, P. H.; Ahn, Y. H.; Bang, O. Y. STem cell Application Researches and Trials In NeuroloGy (STARTING) collaborators. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28(6):1099–1106; 2010.
41. Luo, L.; Chen, D.; Qu, Y.; Wu, J.; Li, X.; Mu, D. Association between hypoxia and perinatal arterial ischemic stroke: A meta-analysis. PloS One 9(2):e90106; 2014.
42. Mazzini, L.; Mareschi, K.; Ferrero, I.; Miglioretti, M.; Stecco, A.; Servo, S.; Carriero, A.; Monaco, F.; Fagioli, F. Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: A long-term safety study. Cytotherapy 14(1): 56–60; 2012.
43. Ohshima, M.; Taguchi, A.; Tsuda, H.; Sato, Y.; Yamahara, K.; Harada-Shiba, M.; Miyazato, M.; Ikeda, T.; Iida, H.; Tsuji, M. Intraperitoneal and intravenous deliveries are not comparable in terms of drug efficacy and cell distribution in neonatal mice with hypoxia-ischemia. Brain Dev. early e-pub; 2014.
44. Pabon, M. M.; Borlongan, C. V. Advances in the cell-based treatment of neonatal hypoxic-ischemic brain injury. Future Neurol. 8(2):193–203; 2013.
45. Phillips, A. W.; Johnston, M. V.; Fatemi, A. The potential for cell-based therapy in perinatal brain injuries. Transl. Stroke Res. 4(2):137–148; 2013.
46. Sasaki, M.; Honmou, O.; Radtke, C.; Kocsis, J. D. Development of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of i.v. infusion of human mesenchymal stem cells. PloS One 6(10):e26577; 2011.
47. Scheibe, F.; Ladhoff, J.; Huck, J.; Grohmann, M.; Blazej, K.; Oersal, A.; Baeva, N.; Seifert, M.; Priller, J. Immune effects of mesenchymal stromal cells in experimental stroke. J. Cereb. Blood Flow Metab. 32(8):1578–1588; 2012.
48. Sheikh, A. M.; Nagai, A.; Wakabayashi, K.; Narantuya, D.; Kobayashi, S.; Yamaguchi, S.; Kim, S. U. Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: Contribution of fractalkine and IL-5. Neurobiol. Dis. 41(3):717–724; 2011.
49. Stemberger, S.; Jamnig, A.; Stefanova, N.; Lepperdinger, G.; Reindl, M.; Wenning, G. K. Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: Immunomodulation and neuroprotection. PloS One 6(5): e19808; 2011.
50. Tang, Y.; Cai, B.; Yuan, F.; He, X.; Lin, X.; Wang, J.; Wang, Y.; Yang, G. Y. Melatonin pretreatment improves the survival and function of transplanted mesenchymal stem cells after focal cerebral ischemia. Cell Transplant. 23(10): 1279–1291; 2014.
51. Theus, M. H.; Wei, L.; Cui, L.; Francis, K.; Hu, X.; Keogh, C.; Yu, S. P. In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Exp. Neurol. 210(2):656–670; 2008.
52. Titomanlio, L.; Kavelaars, A.; Dalous, J.; Mani, S.; El Ghouzzi, V.; Heijnen, C.; Baud, O.; Gressens, P. Stem cell therapy for neonatal brain injury: Perspectives and challenges. Ann. Neurol. 70(5):698–712; 2011.
53. Tsai, L. K.; Wang, Z.; Munasinghe, J.; Leng, Y.; Leeds, P.; Chuang, D. M. Mesenchymal stem cells primed with valproate and lithium robustly migrate to infarcted regions and facilitate recovery in a stroke model. Stroke 42(10): 2932–2939; 2011.
54. Uria-Avellanal, C.; Robertson, N. J. Na(+)/H(+) exchangers and intracellular pH in perinatal brain injury. Transl. Stroke Res. 5(1):79–98; 2014.
55. van Handel, M.; Swaab, H.; de Vries, L. S.; Jongmans, M. J. Behavioral outcome in children with a history of neonatal encephalopathy following perinatal asphyxia. J. Pediatr. Psychol. 35(3):286–295; 2010.
56. van Velthoven, C. T.; Kavelaars, A.; Heijnen, C. J. Mesenchymal stem cells as a treatment for neonatal ischemic brain damage. Pediatr. Res. 71(4 Pt 2):474–481; 2012.
57. van Velthoven, C. T.; Kavelaars, A.; van Bel, F.; Heijnen, C. J. Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain. Brain Behav. Immun. 25(7):1342–1348; 2011.
58. van Velthoven, C. T.; Sheldon, R. A.; Kavelaars, A.; Derugin, N.; Vexler, Z. S.; Willemen, H. L.; Maas, M.; Heijnen, C. J.; Ferriero, D. M. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke 44(5): 1426–1432; 2013.
59. Verina, T.; Fatemi, A.; Johnston, M. V.; Comi, A. M. Pluripotent possibilities: Human umbilical cord blood cell treatment after neonatal brain injury. Pediatr. Neurol. 48(5): 346–354; 2013.
60. Walker, P. A.; Shah, S. K.; Jimenez, F.; Aroom, K. R.; Harting, M. T.; Cox, C. S.Jr. Bone marrow-derived stromal cell therapy for traumatic brain injury is neuroprotective via stimulation of non-neurologic organ systems. Surgery 152(5): 790–793; 2012.
61. Wang, F.; Maeda, N.; Yasuhara, T.; Kameda, M.; Tsuru, E.; Yamashita, T.; Shen, Y.; Tsuda, M.; Date, I.; Sagara, Y. The therapeutic potential of human umbilical cord blood transplantation for neonatal hypoxic-ischemic brain injury and ischemic stroke. Acta Med. Okayama 66(6):429–434; 2012.
62. Wang, S. P.; Wang, Z. H.; Peng, D. Y.; Li, S. M.; Wang, H.; Wang, X. H. Therapeutic effect of mesenchymal stem cells in rats with intracerebral hemorrhage: Reduced apoptosis and enhanced neuroprotection. Mol. Med. Rep. 6(4): 848–854; 2012.
63. Wei, L.; Fraser, J. L.; Lu, Z. Y.; Hu, X.; Yu, S. P. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol. Dis. 46(3): 635–645; 2012.
64. Wei, L.; Han, B. H.; Li, Y.; Keogh, C. L.; Holtzman, D. M.; Yu, S. P. Cell death mechanism and protective effect of erythropoietin after focal ischemia in the whisker-barrel cortex of neonatal rats. J. Pharmacol. Exp. Ther. 317(1):109–116; 2006.
65. Wei, N.; Yu, S. P.; Gu, X.; Taylor, T. M.; Song, D.; Liu, X. F.; Wei, L. Delayed intranasal delivery of hypoxicpreconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice. Cell Transplant. 22(6):977–991; 2013.
66. Weitzdoerfer, R.; Pollak, A.; Lubec, B. Perinatal asphyxia in the rat has lifelong effects on morphology, cognitive functions, and behavior. Semin. Perinatol. 28(4):249–256; 2004.
67. Yoo, S. W.; Chang, D. Y.; Lee, H. S.; Kim, G. H.; Park, J. S.; Ryu, B. Y.; Joe, E. H.; Lee, Y. D.; Kim, S. S.; Suh-Kim, H. Immune following suppression mesenchymal stem cell transplantation in the ischemic brain is mediated by TGF-beta. Neurobiol. Dis. 58:249–257; 2013.
68. Yu, S. P.; Wei, Z.; Wei, L. Preconditioning strategy in stem cell transplantation therapy. Transl. Stroke Res. 4(1):76–88; 2013.
69. Zeng, X.; Yu, S. P.; Taylor, T.; Ogle, M.; Wei, L. Protective effect of apelin on cultured rat bone marrow mesenchymal stem cells against apoptosis. Stem Cell Res. 8(3): 357–367; 2012.
70. Zhu, C.; Sun, Y.; Gao, J.; Wang, X.; Plesnila, N.; Blomgren, K. Inhaled nitric oxide protects males but not females from neonatal mouse hypoxia-ischemia brain injury. Transl. Stroke Res. 4(2):201–207; 2013.